DEVELOPMENT OF A PATIENT-DERIVED TUMOUR ORGANOIDS FROM METASTATIC BREAST CANCER FOR ASSESSMENT OF NOVEL CLINICALLY ACTIONABLE TARGETS

被引:0
|
作者
Jagust, P. [1 ]
Vareslija, D. [1 ]
Cocchiglia, S. [1 ]
O'Haloran, P. J. [2 ]
Dablouk, M. O. [2 ]
Brett, F. M. [3 ]
Cryan, J. [3 ]
Beausang, A. [3 ]
Hudson, L. [1 ]
Hill, A. D. K. [1 ]
Young, L. [1 ]
机构
[1] Royal Coll Surgeons Ireland, Dept Surg, Dublin, Ireland
[2] Beaumont Hosp, Dept Neurosurg, Natl Neurosurg Ctr, Dublin, Ireland
[3] Beaumont Hosp, Dept Neuropathol, Natl Neurosurg Ctr, Dublin, Ireland
关键词
D O I
10.1093/bjs/znab117.050
中图分类号
R61 [外科手术学];
学科分类号
摘要
O50
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
    Martini, G.
    Belli, V.
    Napolitano, S.
    Ciaramella, V.
    Ciardiello, D.
    Belli, A.
    Izzo, F.
    Avallone, A.
    Selvaggi, F.
    Tasselli, F. Menegon
    Santaniello, W.
    Franco, R.
    Puig, I.
    Ramirez, L.
    Chicote, I.
    Mancuso, F.
    Caratu, G.
    Serres, X.
    Fasani, R.
    Jimenez, J.
    Ros, J.
    Baraibar, I.
    Mulet, N.
    Della Corte, C. M.
    Troiani, T.
    Vivancos, A.
    Dienstmann, R.
    Elez, E.
    Palmer, H. G.
    Tabernero, J.
    Martinelli, E.
    Ciardiello, F.
    Argiles, G.
    ESMO OPEN, 2023, 8 (03)
  • [42] Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations
    Jiale Zou
    Shuang Wang
    Ningli Chai
    Hua Yue
    Peng Ye
    Peilin Guo
    Feng Li
    Bo Wei
    Guanghui Ma
    Wei Wei
    Enqiang Linghu
    Journal of Nanobiotechnology, 20
  • [43] Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations
    Zou, Jiale
    Wang, Shuang
    Chai, Ningli
    Yue, Hua
    Ye, Peng
    Guo, Peilin
    Li, Feng
    Wei, Bo
    Ma, Guanghui
    Wei, Wei
    Linghu, Enqiang
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [44] Triple negative breast cancer patient-derived xenografts as a translational model for discovery of novel therapeutic targets
    Matossian, Margarite D.
    Burks, Hope E.
    Bowles, Annie C.
    Sabol, Rachel A.
    Hoang, Van T.
    Bunnell, Bruce
    Zuercher, William J.
    Drewry, David H.
    Wells, Carrow
    Moroz, Krzysztof
    Burow, Matthew E.
    Collins-Burow, Bridgette
    CANCER RESEARCH, 2017, 77
  • [45] Development of patient-derived orthotopic xenografts from metastatic colorectal cancer in nude mice
    Roque-Lima, Bruno
    de Tulio Augusto Roque, Caroline Correa
    Begnami, Maria Dirlei
    Peresi, Patricia
    Pereira Lima, Eduardo Nobrega
    Lopes de Mello, Celso Abdon
    Coimbra, Felipe JoseFernandez
    Chojniak, Rubens
    Santos, Tiago Goss
    JOURNAL OF DRUG TARGETING, 2019, 27 (09) : 943 - 949
  • [46] Identification of circulating tumour cells in breast cancer patient-derived xenograft models
    Agnoletto, Chiara
    Minotti, Linda
    Galasso, Marco
    Corra, Fabio
    Baldassari, Federica
    Cairo, Stefano
    Judde, Jean-Gabriel
    Sauvage, Aurelie
    Deas, Olivier
    Pasquali, Lorenzo
    Volinia, Stefano
    CANCER RESEARCH, 2017, 77
  • [47] Establishing patient-derived organoids from human endometrial cancer and normal endometrium
    Katcher, Arielle
    Yueh, Brian
    Ozler, Kadir
    Nizam, Aaron
    Kredentser, Ariel
    Chung, Charlie
    Frimer, Marina
    Goldberg, Gary L.
    Beyaz, Semir
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [48] Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
    Guilhamon, Paul
    Butcher, Lee M.
    Presneau, Nadege
    Wilson, Gareth A.
    Feber, Andrew
    Paul, Dirk S.
    Scuette, Moritz
    Haybaeck, Johannes
    Keilholz, Ulrich
    Hoffman, Jens
    Ross, Mark T.
    Flanagan, Adrienne M.
    Beck, Stephan
    GENOME MEDICINE, 2014, 6
  • [49] Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
    Paul Guilhamon
    Lee M Butcher
    Nadege Presneau
    Gareth A Wilson
    Andrew Feber
    Dirk S Paul
    Moritz Schütte
    Johannes Haybaeck
    Ulrich Keilholz
    Jens Hoffman
    Mark T Ross
    Adrienne M Flanagan
    Stephan Beck
    Genome Medicine, 6
  • [50] Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer
    Oender, Cansu E.
    Ziegler, Teresa J.
    Becker, Ronja
    Brucker, Sara Y.
    Hartkopf, Andreas D.
    Engler, Tobias
    Koch, Andre
    CANCERS, 2023, 15 (14)